SHANGHAI – The hot topic at the 9th DIA China annual meeting was China's proposed entry into the ICH, a global body that facilitates the harmonizing of drug regulations across countries. Acceptance into the ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) would be a major milestone for China's regulatory reform efforts and give the drug industry a leg up on the global stage.